Does expanded genetic testing benefit Jewish women with breast cancer?

Questions To Ask Your Health Care Provider

• I had genetic testing in the past, how can I find out which tests were ordered?
• How can I get a copy of my genetic test results?
• I previously tested negative for the BRCA Ashkenazi Jewish founder mutations. Should I be tested for other BRCA mutations?
• Should I be tested for mutations in other, non-BRCA breast cancer genes?
• Can you refer me to a genetic counselor?
• If I test positive for a mutation in another breast cancer gene, what does that mean for me and my family as far as screening, cancer prevention, and treatment choices?

Open Clinical Trials

The following clinical trials include genetic counseling and testing. 

• NCT02620852: WISDOM Study: Women Informed to Screen Depending on Measures of Risk offers women ages 40-74 the opportunity to undergo risk assessment and genetic testing in order to determine the best breast screening options based on their situation.  
• NCT05562778: Chatbot to maximize hereditary cancer genetic risk assessment. Researchers are testing whether a mobile health platform, known as a "chatbot" can improve rates of genetic testing among Medicaid patients with an elevated risk having an inherited mutation.
• NCT05427240: eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eReach2). This study will look at the effectiveness of offering web-based options for pre/post-test genetic counseling to provide equal or improved timely uptake of genetic services and testing. 
• NCT05694559: Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics. This study will provide genetic testing to 150 Black individuals and families and provide genetic counseling and risk reduction resources to individuals with a mutation linked to increased cancer risk.

Other genetic counseling or testing studies may be found here.